The negative health effects of international air travel are well documented but now it seems that the common elderberry can provide some relief. Associate professor Evelin Tiralongo and Dr. Shirley Wee from Griffith University's Menzies Health Institute Queensland (MHIQ) have completed a clinical trial showing that an elderberry supplement can provide some protection from cold and flu-like symptoms following long-haul flights.
Elderberries are pictured. Photo courtesy of Iprona AG
The negative health effects of international air travel are well documented but now it seems that the common elderberry can provide some relief. Associate professor Evelin Tiralongo and Dr. Shirley Wee from Griffith University's Menzies Health Institute Queensland (MHIQ) have completed a clinical trial showing that an elderberry supplement can provide some protection from cold and flu-like symptoms following long-haul flights.
Intercontinental air travel can be stressful and affect a passenger's physical and psychological wellbeing. While jet lag and fatigue remain the best known problems, holidaymakers also often experience upper respiratory symptoms.
Presenting their results at the 21st annual International Integrative Medicine Conference in Melbourne, the research team showed how elderberry appears to reduce the duration and severity of the cold.
The randomized, double-blind placebo controlled clinical trial was conducted with 312 economy class passengers travelling from Australia to an overseas destination. Cold episodes, cold duration and symptoms were recorded in a daily diary and participants also completed surveys before, during and after travel.
"We found that most cold episodes occurred in the placebo group, but the difference between the placebo and active group was not significant. However, the placebo group had a significantly higher number of cold episode days, and the symptom score in the placebo group over these days was also significantly higher," says Tiralongo. "Complementary medicines are used by two in three Australians, thus increasing the evidence base of these medicines should be at the forefront of our efforts. It's often forgotten that the evidence for various herbal medicines is extract specific."
The trial used capsules containing 300 mg of a standardized, proprietary membrane-filtered elderberry extract which has shown to be effective in working against respiratory bacteria and influenza viruses.
The Griffith study follows recent European research published in the open access journal Current Therapeutic Research which suggests that a combination of Echinacea herb and root extract supplemented with elderberry can be as effective as the conventional antiviral medicine Tamiflu for the early treatment of influenza.
Source: Griffith University
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.